Results 131 to 140 of about 137,505 (333)
Development of an Animal Experimental Model for a Bileaflet Mechanical Heart Valve Prosthesis [PDF]
Suk Jung Choo +9 more
openalex +1 more source
Aspirin discontinuation in long‐term, stable Heart Mate 3 LVAD patients maintained on Vitamin K antagonists did not increase hemocompatibility‐related adverse events. These findings support the safety of simplified antithrombotic therapy and extend randomized evidence for aspirin avoidance to the long‐term management of Heart Mate 3 recipients ...
Melanie Arnreiter +8 more
wiley +1 more source
Treatment Strategies and Risk of Recurrence in Patients With Heart Valve Prosthesis, Staphylococcus aureus Bacteremia, and Possible Endocarditis-A Retrospective Cohort Study. [PDF]
Toth N, Nilson B, Berge A, Rasmussen M.
europepmc +1 more source
The first self-endothelialized titanium-coated glutaraldehyde-fixed heart valve prosthesis within systemic circulation [PDF]
Norbert W. Guldner +7 more
openalex +1 more source
Percutaneous femoro‐femoral V‐A ECMO cannulation was associated with more than a two‐fold lower risk of site bleeding and nearly a six‐fold lower risk of infection compared with surgical cut‐down, with no difference in limb ischemia. Absence of distal perfusion catheterization and larger arterial cannula size were additional modifiable ischemia risk ...
Axel Dimberg +3 more
wiley +1 more source
Background Pulmonary valve replacement (PVR) is the most common valve replacement procedure for pulmonary valve dysfunction in congenital heart diseases (CHD).
Ali Rafati +15 more
doaj +1 more source
Laser texturing of a St. Jude Medical RegentTM mechanical heart valve prosthesis: the proof of concept. [PDF]
Vigano G +6 more
europepmc +1 more source
Transcatheter aortic valve implantation: predictors of procedural success—the Siegburg-Bern experience [PDF]
Aims The purpose of the present analysis was to identify predictors of procedural success of percutaneous transcatheter aortic valve implantation (TAVI). Methods and results We prospectively assessed in-hospital outcome of patients undergoing TAVI at two
Buellesfeld, Lutz +9 more
core
Results of heart valve replacement with the SORIN prosthesis.
From March 1977 to December 1981, 872 patients at our institution underwent valve replacement with a pyrolytic carbon tilting disc prosthesis manufactured in Italy by SORIN-Biomedica. To verify the performance characteristics of this prosthesis, we analyzed the intermediate-term results obtained over a cumulative total of 3,041 patient-years (pt-yr) of
T. Colombo +4 more
openaire +2 more sources

